Clinical Trials at VSC: More Options, New Hope

As part of our commitment to providing state-of-the-art care from the forefront of vascular medicine, VSC’s specialists are actively involved in the investigation of new medications and devices through clinical trials.

Clinical trials are how treatments are investigated, and every FDA-approved treatment in use today (in all medical specialties) was once studied through clinical trials. Before they can become approved treatment modalities, all new medications and devices will be tested and studied through the clinical-trials process.

It’s also important to note that clinical trials, while investigational by their very nature, are designed with rigorous protocols and processes specifically to protect those who enroll as patients. In fact, clinical trials are conducted with the careful and continuous oversight of Investigational Review Boards (IRBs), which exist to protect patient safety.

In addition to improving the practice of vascular medicine, clinical trials also offer additional options — and hope — to individuals not helped by, or ineligible for, current treatments.

To learn more about VSC’s participation in clinical trials and our dedication to helping expand vascular care through research, click here.

VSC Clinical Trials Currently Enrolling Patients

Are you a potential candidate for one of our treatment investigations via clinical trial? Review the studies below, and let us know if you fit the eligibility criteria and are interested in joining one of our trials.

LEOPARD – Heart & Vascular Clinical Trial

Trial Name
Multicenter, Observational, Post-Market, Real World Study to Assess Outcomes of Patients Treated with the AFX System compared to other EVAR devices for Endovascular Abdominal

Aortic Aneurysm Repair
LEOPARD (Looking at EVAR Outcomes by Primary Analysis of Randomized Data)

Condition
Abdominal Aortic Aneurysm

Purpose
The goal of this study is to evaluate the ongoing safety and effectiveness of the AFX endovascular system compared to other similar FDA approved devices in the treatment of abdominal aortic aneurysm (AAA).

Principal Investigator
Andrew Olinde, MD

Eligibility Criteria
Men and women (ages 18 years or older) with infrarenal AAA who are assessed by the investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the study devices.

ClinicalTrials.gov Link
https://clinicaltrials.gov/ct2/show/NCT02407457?term=NCT02407457&rank=1

For more information or to contact us about enrolling in one of our investigations, call us today at (225) 769-4493. You may also schedule a consultation using our easy online form.

shutterstock_70235731

Treatment for your vascular disease is just a phone call or click away. Call (225) 769-4493 or request an appointment online now.